KRAS G12C inhibitor 37
KRAS G12C Inhibitor 37 is a selective small molecule targeting the oncogenic KRAS G12C mutant protein, a key driver in cellular proliferation pathways. It is a valuable research tool for investigating KRAS-driven cancers, with utility demonstrated in both in vitro cellular assays and in vivo preclinical tumor models.
Product Specifications
CAS Number
2241720-04-5
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
C (C=C) (=O) N1CC2 (C1) CCN (CC2) C=3C4=C (C (OCC (F) (F) F) =C (C (C=C) =C4) C5=C6C (=CC=C5C) NN=C6) N=C (N3) N7CC (N (C) C) C7
Molecular Formula
C35H39F3N8O2
Molecular Weight
660.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400977-500 1x 500 µL
TGF-beta (1D11.16.8), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881231-500 1x 500 µL
Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 